trending Market Intelligence /marketintelligence/en/news-insights/trending/gvgm2s_pqn0ynzqf6xut4a2 content esgSubNav
In This List

Former GSK exec joins Aclaris Therapeutics as chief medical officer

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Former GSK exec joins Aclaris Therapeutics as chief medical officer

Aclaris Therapeutics Inc. appointed David Gordon chief medical officer.

Gordon recently served as senior vice president and head of dermatology research at GlaxoSmithKline PLC.

Wayne, Pa.-based Aclaris Therapeutics develops therapies in the areas of medical and aesthetic dermatology as well as immunology.